|
Advertisement
|
 |
|
Editor's Notebook |
Getting Too Comfortable With Technology
Pharmacy technology is a valuable asset, but it is not without errors. |
|
|
Counseling Pearls |
The Fungus Among Us: An Antifungal Review
The incidence of invasive fungal infections has increased significantly. The past decade has seen the introduction of a number of medications with a wider range of action and fewer side effects.
|
Vitamin Deficiencies in Seniors
Most older adults, especially if frail or institutionalized, fail to consume a healthy diet each day. Anemia, cognitive impairment, and infections are some manifestations of mild vitamin deficiencies in the elderly. |
|
 |
|
|
It's the Law |
Generic Manufacturer Liability
Are manufacturers responsible for label changes if the FDA previously found the generic to be bioequivalent to the brand-name drug? |
| |
|
Clinical Corner |
Evaluation of the Treatment of MRSA Infections
Community-acquired MRSA is a new strain that is on the rise. It is crucial to select the right antimicrobial for the type of infection being treated, with newer agents reserved for the most severe cases. |
Management of Catheter-Associated Urinary Tract Infections
Catheterization increases a patient's risk of nosocomial infection and other complications. Existing guidelines have recently been revised to concentrate on prevention, diagnosis, and management. |
| |
|
Consult Your Pharmacist |
Recognizing and Eradicating Tinea Pedis (Athlete's Foot)
This common dermatophytic skin infection is usually caused by Trichophyton rubrum. |
|
|
Educational Spotlight |
A Review of Asbestos and Related Consequences
Significant exposure to hazardous materials has been associated with an increased risk of developing pulmonary illnesses, especially asbestosis, lung cancer, and mesothelioma. |
Hyperthyroidism: Exploring Treatment Strategies
It is important for pharmacists to understand and be able to educate patients about this endocrine disorder and the methods used to treat it. |
| |
|
Carry the US Pharmacist's Platinum Plus® MasterCard credit card!
Carry the only card that helps support our programs and initiatives at no additional cost to you. Simply
click here to apply online today. |
|
|
| Newswire |
|
 |
2009 H1N1 Influenza Pandemic at an End
Washington, DC — According to the World Health Organization (WHO) International Health Regulations Emergency Committee and WHO Director-General Margaret Chan, MD, the 2009 H1N1 influenza pandemic is over. This declaration was based on strong indications that, worldwide, influenza is transitioning toward seasonal patterns of transmission. Out-of-season 2009 H1N1 outbreaks are no longer being seen in most countries, and the intensity of transmission is lower than that reported in 2009 and early 2010. The Emergency Committee said that the virus probably will continue to circulate for some years, taking on the behavior of a seasonal influenza virus. The H1N1 virus has not disappeared; rather, current influenza outbreaks, including those caused by 2009 H1N1, show an intensity similar to that seen during seasonal epidemics. Vigilance remains important, especially in younger age groups and pregnant women. |
|
|
Weight Not a Factor in Birth Control Pill's Effectiveness
New York, New York — The birth control pill is equally effective in women regardless of weight, according to findings by physician-scientists at New York-Presbyterian Hospital/Columbia University Medical Center. The study—the first to compare the pill's effectiveness in women with significant weight differences—refutes a long-held belief that the pill may not reliably prevent pregnancy in obese or overweight women. Lower and higher dosages of the pill were used. "We wanted to study what was actually happening in the ovaries...and not depend on memory," stated Carolyn Westhoff, MD, lead investigator. Not only did an equally small number of women ovulate while consistently taking the pill, but the lower-dose pill appeared to be just as effective as the higher-dose pill in suppressing ovulation in obese women, which is important in terms of blood clot risk. |
|
|
Asthma Risk More Than Double in Adolescents Taking Acetaminophen
Wellington, New Zealand — An international study has found that adolescents who use acetaminophen once a month have more than twice the risk of developing asthma symptoms versus those who never take it. More than 300,000 teens aged 13 and 14 years in 50 countries were administered written and video questionnaires about their frequency of acetaminophen use and their asthma, allergy, and eczema symptoms. Acetaminophen use was associated with "an exposure-dependent increased risk of asthma symptoms," said Richard Beasley, MD, of the Medical Research Institute of New Zealand. Acetaminophen may have a systemic inflammatory effect resulting in enhanced allergic immune responses; it also may prolong symptomatic illness from rhinovirus infections. |
|
|